Novo Nordisk is gradually ending production of human insulin pens, the drugmaker told Reuters, as it spends billions to ramp ...
Novo Nordisk (NVO) reportedly plans to phase out production of its human insulin pens while it ramps up production of other ...
Novo Nordisk is ceasing production of human insulin pens, focusing on newer obesity and diabetes injections. This shift has ...
MSF calls for insulin manufacturers to provide $1 injection pens globally, emphasizing current high prices and limited access ...
Dr Vincent Simpson says the reusable pens reduce plastic waste and could save the NHS money.
This all-encompassing guide investigates the smart insulin pen and its influence on diabetes management. Here's what you need ...
NovoPen ®, the first insulin pen injector, was introduced in 1985. This article reviews the published evidence over two decades of use of the NovoPen ® family of injection devices in diabetes ...
Novo Nordisk said Thursday that it plans to eventually halt all of its human insulin pen production globally, ...
Ahead of World Diabetes Day, Doctors Without Borders (MSF) called on pharmaceutical corporations Eli Lilly, Novo Nordisk, ...
The international medical charity Doctors Without Borders has called on leading pharmaceutical corporations and "all insulin ...
Increased number of diabetes cases is one of the key factors driving the market growth as injection pens are preferred due to their convenience, comfort and simplicity than other traditional methods.
“An insulin pen, which contains a cartridge that holds the insulin, is a convenient way for many people to carry and use ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback